510(k) Report

510(k) · Cleared

Cleared

RPS Adeno Detector Plus

K110722510(k) TraditionalCleared May 17, 201163-day reviewClass I21 CFR 866.3020

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Rapid Pathogen Screening, Inc. · GOD Antigens, Cf (Including Cf Control), Adenovirus 1-33

Cleared on May 17, 2011 as substantially equivalent to K052092 (Rapid Pathogen Screening, 2005) after a 63-day review. Its family tree reaches back 2 generations to 1999.

Decided
May 17, 2011
Review
63 days
Class
Class I
Product code
GOD
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K990630 (1999). No later device cites it as a predicate yet.

  1. Root · 2 generations backK990630 Sas Adeno TestSa Scientific, Inc. · 1999
  2. 1 generation backK052092 RPS Adeno DetectorRapid Pathogen Screening · 2005
  3. This deviceK110722 RPS Adeno Detector PlusRapid Pathogen Screening, Inc. · 2011
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K990630Sas Adeno TestSa Scientific, Inc.1999—
−1K052092RPS Adeno DetectorRapid Pathogen Screening2005—
0 (this device)K110722RPS Adeno Detector PlusRapid Pathogen Screening, Inc.2011—
FIG. 1 — Lineage of K110722, 1999–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GOD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K052092RPS Adeno Detector
Summary page 1
…Serological Reagents [Antigens, Cf (including control) 5.4 Predicate Device Rapid Pathogen Screening, Inc.; RPS Adeno Detector (K052092) 5.5 Device Description Components- The RPS Adeno Detector Plus TM consists of three (3) parts: a Sample Co…
Rapid Pathogen Screening2005—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 3 companies; a new generation was cleared every 6.3 years on median.
  • None of the 2 ancestors has a recall.

How does its category compare?

All GOD devices

GOD Antigens, Cf (Including Cf Control), Adenovirus 1-33: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · GOD

1in 2011

2011: 1
2007high 1 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GOD

Too few GOD 510(k)s in any year since 2007 to give a median.

Recalls per year · GOD

No recall names GOD since 2007.

Adverse event reports per year · GOD

No MAUDE report names GOD since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20111—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The RPS Adeno Detector Plus is a rapid immunoassay test for the visual, qualitative

in-vitro detection of Adenoviral antigens (hexon protein) directly from human eye

fluid. The test is intended for use as an aid in the rapid differential diagnosis of acute

conjunctivitis.

Negative results do not preclude Adenovirus infection nor are they intended to rule

out other microbial-caused infections of the conjunctiva, and should not be used as

the sole basis for treatment or other management decisions.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K110722: RPS Adeno Detector Plus.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K110722

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026